CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis

Tissue Antigens

Volumn 53, Issue 3, 1999, Pages 296-300

  Gonzalez Escribano, M F ^a   Rodriguez, R ^a   Valenzuela, A ^a   Garcia, A ^a   Garcia Lozano, J R ^a   Nunez Roldan, Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

CTLA4; HLA DR; PCR ARMS; Rheumatoid arthritis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR3 ANTIGEN;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ARTHRITIS, RHEUMATOID; FEMALE; GENOTYPE; HLA-DR3 ANTIGEN; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; MALE; POLYMORPHISM, GENETIC; RECOMBINANT FUSION PROTEINS; SPAIN;

EID: 0033065858     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530311.x     Document Type: Article

References (23)

1. Stastny P. Association of the B cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978: 298: 869-71.
2. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypotesis: an approach to understand the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987: 30: 1205-13.
3. Sánchez B, Moreno I, Magarin̄o R et al. HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 1990: 36: 174-6.
4. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994: 56: 389-466.
5. Weyand CM, Goronzy JJ. Inherited and noninherited risk factors in rheumatoid arthritis. Curr Opin Rheumatol 1995: 7: 206-13.
6. Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr Opin Immunol 1996: 8: 822-30.
7. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity, 1997: 7: 445-50.
8. Deichmann K, Heinzmann A, Brüggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA-4 promotor. Biochem Biophys Res Commun 1996: 225: 817-8.
9. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activate lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991: 147: 1037-44.
10. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human CTLA-4 gene. Nucleic Adds Res 1991: 19: 4018.
11. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996: 5: 1075-80.
12. Donner H, Rau H, Walfish PG et al. CTLA-4 Alanine-17 confers genetic susceptibility to Graves' disease and to type I diabetes mellitus (IDDM). J Clin Endocrinol Metab 1997: 82: 143-6.
13. Seidl C, Donner H, Fischer B et al. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998: 51: 62-4.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of the rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
15. Kawasaki E. Sample preparation from blood, cells and other fluids. In: Innis M, Gelfand D, SniskyJ, White T, eds. PCR protocols. A Guide to Methods and Applications, San Diego: Academic Press, 1990: 146-52.
16. Bignon JD, Fernández-Viña MA. Protocols of the 12th International Histocompatibility Workshop for typing of HLA class II alleles by DNA amplification by the polymerase chain reaction (PCR) and hybridation with sequence specific oligonucleotide probes (SSOP). In: Charron D, ed. Genetic diversity of HLA functional and medical implications. Paris: EDK, 1997: 584-95.
17. Fernández-Viña MA, Bignon JD. Primers and oligonucleotide probes (SSOP) used for DNA typing for DNA of HLA class II alleles. In: Charron, D ed. Genetic diversity of HLA functional and medical implications. Paris: EDK, 1997: 596-632.
18. Woolf B. On stimating the relation between blood group and disease. Ann Hum Genet 1955: 19: 251-3.
19. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996: 4: 535-43.
20. Leung HT, Bradshaw J, Cleaveland J, Linsley PS. Cytotoxic T. lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J Biol Chem 1995: 270: 25107-14.
21. Rhodes K, Scott A, Markhan RL, Monk-Jones ME. Immunological sex differences. Ann Rheum Dis 1969: 28: 104-19.
22. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985: 121: 531-51.
23. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves disease in a caucasian population. J Clin Endocrinol Metab 1995: 80: 41-5.